Zobrazeno 1 - 4
of 4
pro vyhledávání: '"C. Steven Ernest II"'
Autor:
Rodney L. Decker, C. Steven Ernest II, David B. Radtke, Rona Wang, Joana Araújo, Stuart Y. Keller, Xin Zhang
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 13, Iss 6, Pp 970-981 (2024)
Abstract Baricitinib is approved for the treatment of rheumatoid arthritis (RA) in more than 70 countries, and juvenile idiopathic arthritis (JIA) in the European Union. Population pharmacokinetic (PK) models were developed in a phase 3 trial to char
Externí odkaz:
https://doaj.org/article/cabc28d70a48442d8a69bd4e181985ce
Autor:
Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua, Kay Chow, C. Steven Ernest II, Jian Wang, Sergey Shcherbinin, John R. Sims, Emmanuel Chigutsa
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 9, Iss 2, Pp n/a-n/a (2023)
Abstract INTRODUCTION Donanemab is an amyloid‐targeting therapy that specifically targets brain amyloid plaques. The objective of these analyses was to characterize the relationship of donanemab exposure with plasma biomarkers and clinical efficacy
Externí odkaz:
https://doaj.org/article/46f199eccdf94cd1a9b67b5c825effb4
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 11, Iss 6, Pp 721-730 (2022)
Abstract The relationship between severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral load reduction and disease symptom resolution remains largely undefined for coronavirus disease 2019 (COVID‐19). While the vaccine‐derived
Externí odkaz:
https://doaj.org/article/be2b0aade26f485a856c7e33c10b4790
Autor:
Wrishko, Rebecca E., C. Steven Ernest, II, Small, David S., Li, Ying G., Weerakkody, Govinda J., Riesmeyer, Jeffrey R., Macias, William L., Rohatagi, Shashank, Salazar, Daniel E., Antman, Elliott M., Wiviott, Stephen D., Braunwald, Eugene, Lan Ni
Publikováno v:
Journal of Clinical Pharmacology; Aug2009, Vol. 49 Issue 8, p984-998, 15p